| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
|
J Clin Oncol
|
1994
|
1.44
|
|
2
|
Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapy.
|
Cancer J Sci Am
|
1997
|
1.38
|
|
3
|
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.
|
Am J Clin Oncol
|
1988
|
0.90
|
|
4
|
Role of blood groups as prognostic factors in primary breast cancer.
|
Oncology
|
1990
|
0.89
|
|
5
|
Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis.
|
Oncology
|
2011
|
0.85
|
|
6
|
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience.
|
Semin Oncol
|
1995
|
0.85
|
|
7
|
Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial.
|
Tumori
|
1999
|
0.83
|
|
8
|
Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer.
|
J Cancer Res Clin Oncol
|
1990
|
0.81
|
|
9
|
A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
|
Eur J Surg Oncol
|
2013
|
0.81
|
|
10
|
Doxorubicin distribution in human breast cancer.
|
Cancer Treat Rep
|
1987
|
0.81
|
|
11
|
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients.
|
Cancer
|
1986
|
0.81
|
|
12
|
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
|
Cancer
|
1994
|
0.80
|
|
13
|
Esophageal involvement in breast cancer. Report of six cases.
|
Tumori
|
1982
|
0.79
|
|
14
|
A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.
|
Adv Exp Med Biol
|
1988
|
0.78
|
|
15
|
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study.
|
J Cancer Res Clin Oncol
|
1997
|
0.78
|
|
16
|
Alternating chemo-radiotherapy in bladder cancer: a conservative approach.
|
Int J Radiat Oncol Biol Phys
|
1995
|
0.78
|
|
17
|
Phase II study of navelbine in advanced renal cell carcinoma.
|
Eur J Cancer
|
1991
|
0.78
|
|
18
|
Cardiac arrhythmia: possible complication from treatment with cisplatin.
|
Tumori
|
1986
|
0.76
|
|
19
|
Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination.
|
Oncology
|
1986
|
0.76
|
|
20
|
Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancer.
|
Cancer Invest
|
1988
|
0.75
|
|
21
|
Role of administration route in the therapeutic efficacy of doxifluridine.
|
J Natl Cancer Inst
|
1987
|
0.75
|
|
22
|
Low-dose cisplatin and etoposide in advanced non-small cell lung carcinoma.
|
Tumori
|
1984
|
0.75
|
|
23
|
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial.
|
Cancer Chemother Pharmacol
|
2011
|
0.75
|
|
24
|
Low activity of circadian continuous fluorodeoxyuridine (fudr) chemotherapy in poor-prognosis metastatic renal-cancer.
|
Oncol Rep
|
1994
|
0.75
|
|
25
|
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer.
|
Chemioterapia
|
1986
|
0.75
|
|
26
|
Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.
|
J Cancer Res Clin Oncol
|
1985
|
0.75
|
|
27
|
Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II study.
|
Eur J Cancer Clin Oncol
|
1987
|
0.75
|
|
28
|
Phase II trial of thioproline in advanced epidermoid head and neck tumors.
|
Cancer Treat Rep
|
1982
|
0.75
|
|
29
|
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung.
|
Cancer Treat Rep
|
1986
|
0.75
|
|
30
|
Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
|
Int J Clin Pharmacol Ther Toxicol
|
1987
|
0.75
|
|
31
|
[Biological tumor markers].
|
Arch Monaldi Mal Torace
|
1994
|
0.75
|
|
32
|
Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patients.
|
Anticancer Res
|
1989
|
0.75
|
|
33
|
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer.
|
Am J Clin Oncol
|
1987
|
0.75
|
|
34
|
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma.
|
Eur J Cancer
|
1992
|
0.75
|
|
35
|
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
|
Eur J Cancer Clin Oncol
|
1987
|
0.75
|
|
36
|
Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
|
Cancer Treat Rep
|
1986
|
0.75
|
|
37
|
Hematologic parameters during treatment with high-dose medroxyprogesterone acetate.
|
Tumori
|
1981
|
0.75
|
|
38
|
[Secondary prevention of pulmonary carcinoma].
|
Arch Monaldi Mal Torace
|
1994
|
0.75
|
|
39
|
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC).
|
Cancer Invest
|
1988
|
0.75
|
|
40
|
Gas chromatographic determination of two fluorinated benzodiazepines in rats and mice.
|
J Chromatogr
|
1980
|
0.75
|